/biz/ - Business & Finance

I'm really bummed about SEEL. The company seems great on paper.
>The Seelos Way
>Assets must serve a large unmet medical need, orphan population or a unique approach to existing treatments
>Assets must possess extensive scientific rationale and/or existing human data
>Seelos will look for clinically ready assets or assets where minimal pre-clinical work will be needed
>The clinical development pathway should make economic sense and be appropriate for a company our size

Am I reading this right? They're basically just a VC firm that buys stage2/3 drugs already proven to work.
The board of directors seems fine too. Pajeets should be good VCs, no?

It should short squeeze on monday, but with my luck it'll head to 1.5, I'll sell, and then it'll squeeze to 10.